The Sentinel Initiative was launched in 2008 to monitor safety of approved medical products using real-time data from electronic health records and claims databases. Which statement best describes its goal?

• A. Real-time safety monitoring of approved medical products
• B. Regulation of medical devices
• C. Enforcement of drug schedules
• D. Pharmacovigilance only for vaccines

Answer: (A)

Real-time safety monitoring of approved medical products is what the Sentinel Initiative aims for. It’s an FDA program designed to continuously watch for safety signals after products are on the market, using large real-world data sources like electronic health records and claims databases to spot potential adverse effects as they appear. This real-time, post-market surveillance helps inform risk management and regulatory decisions if safety concerns emerge. The other options don’t fit because the initiative isn’t about regulating devices, enforcing drug schedules, or limiting pharmacovigilance to vaccines; it covers safety monitoring across a broad range of approved medical products.